Main Menu

• Home
• About Us
  • Selected Bios
    • Ellen V. Sigal
    • Marlene A. Malek
    • Jeff D. Allen
    • Ryan M. Hohman
    • Heather S. Chaney
    • Samantha Roberts
    • Jessica Walrath
    • Ellen V. Sigal, Chair & Founder
    • Marlene A. Malek, President
    • Jeff Allen, Executive Director
    • Ryan M. Hohman, Director, Communications & Policy
    • Pamela Riker, Senior Development Manager
  • Board of Directors
  • Scientific Advisory Board
• News & Events
  • In The News
    • CQ - While Disparities Persist, Cancer Screening Rates Equalize for African Americans
    • Inside Health Policy - FDA 2013 Approps Clouded By Unclear Impact of User Fees, Sequestration
    • Washington Post - PCORI: Funny acronym, serious work
    • Bloomberg - Drug Approvals Hit a Seven-Year High in 2011 on Improved Data
    • Reuters - Cancer rates in U.S. keep falling: report
    • Reuters - Targeted drug side effects add to cancer costs
    • WSJ - ‘War on Cancer’ Celebrates 40th Anniversary; What’s Next?.
    • FierceBiotech - Spike in approvals can't quell industry complaints about FDA
    • NYT - Scientific Panel Finds Few Clear Environmental Links to Breast Cancer
    • NYT - F.D.A. Revokes Approval of Avastin as Breast Cancer Drug
    • CER Priorities in Oncology Released
    • Reuters - FDA says drugs approved in U.S. before Europe
    • NYT - Obama Tries to Speed Response to Shortages in Vital Medicines
    • The Hill - The Prescription Drug and User Fee Act: An opportunity for progress in science and innovation
    • Reuters - Senators propose relaxing FDA conflict rules
    • NYT - U.S. Panel Advises Against Routine Prostate Test
    • Reuters - Cancer cost "becoming unsustainable" in rich nations
    • AACR CANCER PROGRESS REPORT
    • WSJ - Drug Shortages Threaten Cancer Research
    • CQ - Senate Appropriations Panel Trims NIH but Administers Half-Billion-Dollar Jolt to Drug Development
    • Bloomberg - NIH Budget Cuts May Slow Personalized Cancer Drugs, Group Says
    • CQ - Obama plan would make $320 billion in health cuts, including Medicare, Medicaid
    • CQ - FDA Reorganizes Approval of Cancer Therapies
    • Reuters - FDA may get two more months to review new drugs
    • WSJ - FDA, Brand Drug Firms Agree on Increased Fees
    • WSJ - When a Doctor Isn't Enough
    • Reuters - Gene therapy shown to destroy leukemia tumors
    • The Scientist - Debt Ceiling Bill May Hurt Science
    • Wall Street Journal - America's Innovation Agency: The FDA
    • WSJ - Drug Makers Refill Parched Pipelines
    • Roll Call - Sigal: FDA Requires Support, Funds to Continue Research
    • Reuters - Study: Cancer drugs approved in U.S. before Europe
    • The RPM Report - CATT in the Eye of the Beholder: Top Government Officials React to Comparative Study
    • WSJ - Major Shift in War on Cancer
    • Washington Post - NIH human clinical trials look for causes and cures for disease
    • The Economist - The costly war on cancer
    • CNBC - The Arrival of Personalized Medicine
    • WSJ - Sanofi’s Zerhouni On Translational Research: No Simple Solution.
    • The New York Times - The Voices of Childhood Cancer
    • National Journal - The Late Sen. Stevens' Spouse Fights a New Battle
    • SF Gate - Scientific progress starts with us
    • The Washington Examiner - To cut costs, health care needs much more info
    • CQ - Report: More Research Needed on Causes of Cancer Among Minorities
    • The Atlantic - People, or Rules?
    • GenomeWeb - Comparative Effectiveness Research to Advance Personalized Rx in FDA's Five-Year Plan
    • The Wall Street Journal - Making Clinical Trials Less of a Tribulation
    • The Pink Sheet - PDUFA V: FDA Relaxes Pre-Submission Meeting Requirement
    • Nature - Transparency initiative moves ahead despite official’s departure
    • NEJM - Development of Novel Combination Therapies
    • Inside Health Policy - Bennet To Expand Drug Safety Bill, Expected To Gain GOP Support
    • Inside Health Policy - FDA's Initial CER Studies To Develop Trial Designs, Analytic Software
    • GW Today - Eliminating Breast Cancer Disparities
    • Voices of Survivors - 'My Voice' by Pamela Grossman
    • The Pink Sheet - PCORI Board Lays CER Groundwork With Environmental Scans, “Tier 1” Grants
    • FDA and Its Regulated Industries Are a Cornerstone of U.S. Economic Growth
    • CQ - First Steps on Comparative Effectiveness Grants Expected Next Week
    • Politics Daily - The GOP Budget and Cancer -- Why New Research Is at Risk
    • Press Release - FDA and Georgetown University Medical Center announce partnership
    • Nature - It takes two to tango: FDA ponders a new regulatory dance
    • RPM Report - How To Strengthen a Chronically Underfunded FDA: Cut Funding
    • WSJ - Health-Care Investment—The Hidden Crisis
    • Washington Post Letter to the Editor - Drug approval isn't a race between the U.S. and the E.U.
    • The New York Times - Awaiting Health Law's Prognosis
    • CQ - Comparative Effectiveness Institute Ramps Up Work
    • Health Affairs - HHS Secretary Kathleen Sebelius: Building a Stronger Foundation for a New Century of Treatments and Cures
    • HHS - New report: 129 million Americans with a pre-existing condition could be denied coverage without new health reform law
    • WSJ - Cancer-Care Costs Could Hit $207 Billion in 2020: NCI Study
    • U.S. News and World Report - Quality of Life Key Measure in Breast Cancer Clinical Trials
    • The Wall Street Journal - Regulator Defends Avastin Decision
    • The Pink Sheet - FDA Draft Co-Development Guidance Emphasizes Phase II Studies
    • Reuters - U.S. and Europe to limit use of Roche's Avastin
    • WSJ - FDA: Here’s How to Develop Drug Combinations
    • Reuters - Elizabeth Edwards dies
    • The Pink Sheet - Observational Study Guidance Needed for CER
    • Fuel Lines of Tumors Are New Target
    • The Wall Street Journal - Medicare to Review Cancer Treatment
    • Reuters - FDA chief urges caution on budget cut
    • The Wall Street Journal - 'Too Young for Cancer' and Demanding Action
    • Science Based Medicine - Integrating patient experience into research and clinical medicine: Towards true “personalized medicine”
    • The New York Times - CT Scans Can Reduce Lung Cancer Deaths, Study Finds
    • The Pink Sheet - CER Could Be A Barrier To Innovation, Venture Capitalist Says
    • The New York Times - New DNA Tests Aimed at Reducing Colon Cancer
    • The Health Care Blog - How Come Comparative Effectiveness Research is All the Rage?
    • WSJ Health Blog - Prevention Task Force Cancels Nov. Meeting; Would Have Included Prostate Screening Vote
    • Kaiser Health News- Daschle On Health Law: Defunding Is 'A Very Serious Threat'
    • Reuters- UnitedHealth seeks change to reimbursing for cancer drugs
    • San Francisco Business Times- Cancer network favors Avastin — mostly
    • Wash Post: New government panel's mission is to empower public with health-care knowledge
    • Regulatory Science: A Biodefense Backlash?
    • AP- FDA plans to collaborate with outside researchers to improve food, drug science
    • NPR- Court: Stem Cell Funds Can Continue For Now
    • Wall Street Journal - Health Insurers Finally Get Some Oversight
    • The Hill- GAO announces appointments to comparative-effectiveness board
    • NY Times- Mammograms’ Value in Cancer Fight at Issue
    • New York Times- New Drugs Stir Debate on Basic Rules of Clinical Trials
    • NY Times- Is Newer Better? Not Always
    • AP- Appeals court allows stem cell funding for now
    • Reuters- Obama administration appeals stem cell injunction
    • Washington Post- NIH cuts off stem cell funding after court order
    • Reuters- U.S. court rules against Obama's stem cell policy
    • LA Times- Avastin shouldn't make the FDA give up on 'accelerated approval' of drugs
    • Washington Post-FDA considers revoking approval of Avastin for advanced breast cancer
    • FORTUNE- The preventative medicine problem: nobody wants it
    • DNA Test May Speed Colon Cancer Diagnosis
    • AP- Health Care Reform Provisions To Go Into Effect Next Month
    • Reuters- U.S. panel rejects Roche's Avastin for breast cancer
    • Reuters- U.S. Advisers Say Keep Glaxo's Avandia on the Market
    • Science Mag- Varmus Targets 'Dysfunction,' Scientific Barriers in Cancer Research
    • The Kansas City Star- Turning science into drugs a trial
    • Lawrence Journal World- Sebelius calls for expedited drug process
    • HHS Secretary Sebelius Joins Leaders from the National Institutes of Health, Food & Drug Administration and Academia to Discuss New Roles in Drug Discovery and Development
    • Boston Globe- Rethinking cancer treatment
    • Health Affairs- Rapid Learning And Cancer Care: Time To Move Forward
    • Reuters- Pfizer pulls leukemia drug from U.S. market
    • Economist- A decade after the human-genome project, writes Geoffrey Carr, biological science is poised on the edge of something wonderful
    • Inside Health Policy- FDA Struggles With How To Regulate Co-Development Of Drugs, Seeks Input
    • CNN- Three questions with Dr. Francis Collins
    • WSJ- A New Way to Treat Brain Cancer?
    • Science Magazine- Francis Collins: On Recruiting Varmus, Discovering Drugs, the Funding Cliff
    • Washington Post- Ex-NIH chief and Nobel winner returns to lead National Cancer Institute
    • New York Times- Nobelist Is Chosen to Fill Cancer Post
    • The Scientist- Fate of science "hero" uncertain
    • WHYY- Biomedical community watching primary closely
    • Business Week- Prostate Cancer Vaccine May Get FDA Approval
    • NY Times- Faltering Cancer Trials
    • New York Times- Cancer Fight: Unclear Tests for New Drug
    • Washington Times- WEINER & BERG: 'Failure' is the wrong diagnosis
    • Bloomberg- Cancer Research by U.S. Disorganized, Underfunded, Study Says
    • WSJ- Another Cancer Battle: Costs
    • Francis Collins on CER and Personalized Medicine
    • Washington Post- John Dingell's health-care moment
    • Washington Post- Conversations: NIH Director Francis S. Collins
    • JAMA- Charting a Path From Comparative Effectiveness Funding to Improved Patient-Centered Health Care
    • The President's Remarks on Health Care
    • The Center for Health Transformation- Research is the Foundation of All New Advances in Medicine
    • Boston Globe - To trim medical costs, apply ‘best practices’
    • Chronicle of Higher Education- On Climate Controversies and AIDS Research, Scientists Reach Out to the Public
    • Annals of Internal Medicine- When Evidence Collides With Anecdote, Politics, and Emotion: Breast Cancer Screening
    • WSJ- A Simple Health-Care Fix Fizzles Out
    • WSJ- Public Health Tab to Hit Milestone
    • Freeze? What freeze? FDA in line for another budget boost
    • AP- Rangel: Lawmakers writing compromise health bill
    • Philadelphia Inquirer- FDA has more work, less money
    • Text: President Obama’s State of the Union Address
    • New York Times- As Technology Surges, Radiation Safeguards Lag
    • Politico- Five key health reform questions
    • Reuters- SCENARIOS-U.S. healthcare bill faces uncertain fate
    • ABC NEWS- Obama: Seat Scott Brown and Health Care Next Steps
    • New York Times- Democrats May Seek to Push Health Bill Through House
    • Washington Post- Meet the conference committee
    • HOUSE-SENATE COMPARISON OF KEY PROVISIONS
    • Washington Post- During health-care vote, Ted Kennedy is gone -- but not forgotten
    • New York Times- Old Ideas Spur New Approaches in Cancer Fight
    • Politico- Group mobilizes against new recs
    • New York Times- When Lowering the Odds of Cancer Isn’t Enough
    • New York Times- Cancer Society Protests Senate’s Proposed Cap on Benefits
    • WSJ- The Imprecision Behind Mammogram Guidance
    • WSJ- Cancer Rates Continue to Fall in the U.S.
    • The Associated Press- Senate casts 1st votes to overhaul health care
    • Washington Post- Fighting a smarter war on cancer
    • Washington Post- Behind Cancer Guidelines, Quest for Data
    • Washington Post- Let's stick with mammograms
    • SEBELIUS STATEMENT ON NEW BREAST CANCER RECOMMENDATIONS
    • Washington Post- Breast exam guidelines now call for less testing
    • Indy Star- Vera Bradley Foundation to give another $10M to IU cancer center
    • Health Bill Garners Endorsements
    • Washington Post- FDA initiative targets drug prescription, dosing errors
    • Pink Sheet- CER And Personalized Medicine Are "Synergistic" - FDA's Woodcock
    • New York Times- A Place Where Cancer Is the Norm
    • The Hill- How the two Senate bills measure up
    • New York Times- Merging the Senate Bills
    • Philadelphia Inquirer- A few seconds for science
    • Reuters- Rep. DeLauro, Administration Urge Congress to Improve the Safety of Imported Food
    • Fortune-FDA chief: Regaining your trust
    • AP- Another GOP senator open to health overhaul
    • RPM Report Interview with Ellen Sigal
    • New York Times- Health Care Bill Gets Green Light in Cost Analysis
    • Wall Street Journal- Hospitals Find Way to Make Care Cheaper -- Make It Better
    • New York Times- For N.I.H. Chief, Issues of Identity and Culture
    • Associated Press -Obama Announces $5 Billion in Health-Research Grants
    • Wall Street Journal- Making Sense of the Debate on Health Care
    • USA TODAY-Health care comparisons help show best practices, prices
    • Pink Sheet- FDA Will Revisit Appropriate Use Of PFS Endpoints At Advisory Committee
    • New York Times- Where Cancer Progress Is Rare, One Man Says No
    • Wall Street Journal- Baucus Crafts Health Care Plan, But Senate Democrats Have Concerns
    • Washington Post- Dodd Decides Against Taking Over Senate Health Committee
    • New York Times- Health Compromise Floated Before Obama Speech
    • Wall Street Journal- Bleak Cancer Reports Mask Major Advances
    • Huffington Post- The Future We Make: Ted Kennedy's Legacy in Fighting Cancer
    • New York Times- The Selling of the Policy
    • LA Times- Amid the acrimony, Congress has consensus on some healthcare issues
    • Washington Post- Massachusetts Sen. Ted Kennedy Dies at 77 After Cancer Battle
    • Newsweek- Five Important Health Care Reforms We Aren't Talking About
    • New York Times- Disparities: Study Finds Risk in Off-Label Prescribing
    • New York Times- Daschle Has Ear of White House and Industry
    • Huffington Post- Solving the Healthcare Reform Puzzle
    • Boston Globe- Dispute widens on merits of health tests
    • Reuters- Drug compound kills breast cancer stem cells
    • New York Times-10 Steps to Better Health Care
    • The New York Times-Why Patients Turn Down Clinical Trials
    • The New York Times- A Primer on the Details of Health Care Reform
    • New York Times- To Fight Cancer, Know the Enemy
    • New York Times- Lack of Study Volunteers Hobbles Cancer Fight
    • AP- Dodd has prostate cancer
    • Washington Post- Baucus Touts Lower Cost of Compromise Health-Care Bill
    • Washington Post- Key Lawmakers Restart Health-Care Talks
    • NPR- Health Effects Of Comparing Care: No Easy Answers
    • Newsweek- ‘The Cause of My Life’... Inside the fight for universal health care.
    • DOW JONES NEWSWIRES - US Senate Panel Approves 12-Year Biologic Drug Exclusivity
    • NY Times- Health Reform, a Cancer Offers an Acid Test
    • AP-Which treatment works best?
    • Time- How to Cut Health-Care Costs: Less Care, More Data
    • USA TODAY- FDA has a lot on its plate' as new chief takes over
    • New York Times- Senate Moves Forward on Health Care
    • MSNBC- How numbers crunchers shape health reform
    • Nextgov- Health professionals call for network to uncover best medical treatments
    • LA Times-Healthcare overhaul effort moves forward without Kennedy
    • Boston Globe- Health bill would fix what's broken
    • The FDA as a Public Health Agency
    • Pink Sheet- House Comparativeness Effectiveness Bill includes “Physician Out” Clause
    • NCI- Comparative Effectiveness Research Stirs Excitement as Well as Debate
    • Associated Press- Nominee to Lead FDA Confirmed By Senate
    • Wall Street Journal- Health Costs Are the Real Deficit Threat
    • The Pink Sheet- Senate Adding Safeguards Against Direct Link Between Comparative Effectiveness Research, Coverage Decisions
    • NPR: Orszag: Health Coalition's Plan A 'Significant' Step
    • Washington Post- Senators Offer Their Support to F.D.A. Nominee
    • Wall Street Journal- Obama Wants Additional $300 Million for FDA
    • AACI, AACR, ASCO, and Friends host Hill Day 2009, and Honor Senator Arlen Specter
    • Power for patients: Comparative effectiveness research will help people make better health choices
    • Sebelius Confirmation Expected Today
    • New York Times- Health Care Reform, Step One
    • New York Times- Advances Elusive in the Long Drive to Cure Cancer
    • CQ- ‘White Paper’ Aims to Shape Treatment Comparison Agenda
    • Washington Post- Local, State Agencies Lack Resources to Ensure Food Safety
    • Comparative effectiveness research panel holds first session
    • Wall Street Jounral- Push to Compare Treatments Worries Drug, Device Makers Article
    • Washington Post- Obama Makes Health Reform Office Official
    • Wall Street Journal- Torti’s Farewell Memo to FDA Staff: ‘Take the FDA Back’
    • FDA Week- Sentinel Could Help Choose Comparative Effectiveness Projects
    • Houston Chronicle- Now’s time to reinvigorate country’s War on Cancer
    • Washington Post- After Cancer, Lawmaker Urges Tests
    • Dow Jones- Roche's Herceptin Extends Life In Aggressive Stomach Cancer
    • Comparison Shopping for Medicine
    • Obama to tap Hamburg to run FDA
    • FDA Pick Was NYC Health Chief
    • RPM Report - FDA Commissioner Hamburg: Administration Closing In On Official Announcement
    • Wall Street Journal - Obama, Health-Care Players Agree to Seek Overhaul
    • Washington Post - White House forum to diagnose health care ills
    • WSJ - Obama Taps Sebelius for Health and Human Services Secretary
    • New York Times - On Health, President Takes Team Approach
    • WSJ - The Next Front in the War on Cancer
    • Reuters - Obama Cancer Cure Vow Requires More Funds: Experts
    • The Scientist - Flat funding for NIH in 2009
    • Reuters-Sebelius says has not discussed health post with Obama
    • The Huffington Post- Why Healthcare Can’t Wait
    • New York Times - Specter, a Fulcrum of the Stimulus Bill, Pulls Off a Coup for Health Money
    • The Hill - Dem ‘family politics’ blocks Dean at HHS
    • The Scientist - Biomedical research is ripe for a stimulus
    • Washington Post- I'm Battling Cancer. How About Some Help, Congress?
    • Wall Street Journal - Understanding Justice Ginsburg’s Pancreatic Cancer
    • RPM Report-FDA Commissioner Update: Announcement Timing Provides Clues
    • SystemsTox
    • Reuters: Obama's FDA pick to come within days-spokesman
    • New York Times - Medicare Widens Drugs It Accepts for Cancer
    • Wall Street Journal - CDC Insider Named Acting Director
    • Wall Street Journal - CDC, FDA Set to Get New Leaders
    • New York Times - Daschle Pledges a Bipartisan Reform of Health Care System
    • Boston Globe - The Great Promise of Personalized Medicine
    • Washington Post- Next NIH Director Faces Budget Issues
    • Boston Globe - America Needs a Strong FDA
    • Washington Post - Ailing FDA May Need Major Reconstructing
    • Capitol File- Two Views One Goal
  • Cancer Policy News
    • 2010 CCCR FDA Guidance
    • Groundbreaking Public-Private Collaboration Combines Personalized Medicine and Novel Trial Design to Develop Potentially Life Saving New Breast Cancer Drugs
    • FDA and NIH Collaboration Aims to Speed New Treatments to Patients
    • THE PRESIDENT’S HEALTH CARE PROPOSAL
    • Recovery Act Updates from NCI
    • Video Excerpts of Addresses at 2009 CCCR
    • REMARKS BY THE PRESIDENT ON THE AMERICAN RECOVERY AND REINVESTMENT ACT
    • President Obama Releases FY 2010 Budget:NIH, NCI, FDA all See Increases
  • Press Releases
    • FDA Press Release on Commitment Letter for PDUFA
    • Health Affairs Study
    • Susan G. Komen's "Honoring the Promise" Gala Celebrates Heroes in the Global Fight against Breast Cancer
    • Friends of Cancer Research Video Narrated by Michael Douglas
    • Friends of Cancer Research Statement on Prescription Drug User Fee Act (PDUFA) Agreement
    • New Study Shows that FDA Approves Cancer Drugs Faster Than its European Counterpart
    • Patient-Centered Outcomes Research Institute Names Selby First Executive Director
    • Cancer Organizations Honor Rep. Markey, Advocate for Biomedical Research Funding on Capitol Hill
    • Former NCI Deputy Director Dr. Anna Barker and Attorney and Advocate Catherine Stevens Join Friends Board of Directors
    • FDA and Its Regulated Industries Are a Cornerstone of U.S. Economic Growth and Job Creation
    • New report: 129 million Americans with a pre-existing condition could be denied coverage without new health reform law
    • TEARING DOWN THE SILOS: ADDRESSING SYSTEMATIC BARRIERS IN THE RESEARCH PROCESS
    • White Paper on New Models for Accelerated Drug Discovery and Development Is Released
    • PCORI Board Announcement
    • Stand Up 2 Cancer September 10th
    • Senator Ted Stevens
    • HHS Secretary Sebelius Joins Leaders from the National Institutes of Health, Food & Drug Administration and Academia to Discuss New Roles in Drug Discovery and Development
    • Friends Statement on Appointment of Dr. Varmus
    • Science and Progress at the FDA:Realizing the Return on Investment from Biomedical Research Briefing- Invite
    • Statement on President Obama’s Address to a Joint Session of Congress
    • CER Report Released at Forum with Leading Scientists and Policy-makers
    • Friends of Cancer Research Brings in 2009 with a New Website
    • A Note From Ellen Sigal and Marlene Malek
    • Senator Obama Releases Cancer Plan
    • Senator McCain Releases Cancer Plan
    • Stand Up To Cancer
  • Monthly Newsletter
    • Recent Issues
      • Washington Update: PDUFA Hearing Summary
      • 2011 CCCR Review
      • Washington Update: Sebelius, Hatch, Muhkerjee Honored for 15th Anniversary, Sigal to be Honored at Kennedy Center
      • Washington Update: Congressional Testimony, Sebelius to be Honored
      • Washington Update: FDA vs EMA Study, CER Forum
      • Washington Update: GWU Symposium, MD Anderson Roundtable
      • Regulatory Science White Paper Released
      • July 2010 CER and Kansas Town Hall
      • Comparative Effectiveness Research 2010
      • Washington Update: Friends Testifies, Holds Hill Briefing
      • Washington Update: January 2010
      • HHS Secretary on USPTF Recommendations
      • September 2009 Washington Update
      • Collins Confirmed as NIH Director
      • Institute of Medicine and Federal Coordinating Council Release Important Reports on CER
      • Friends News:President FY2010 Budget, FDA Confirmation, 2009 Hill Day
      • April 2009 Newsletter- Obama/ Specter
      • Winter 2008 Newsletter
      • November/December 2008
      • October 2008
    • Newsletter Archive
      • July 2008
      • June 2008
  • Town Halls
    • Program Archive
      • CCCR
      • Brookings, Friends, AACR and ASCO Host Conference on Clinical Cancer Research
      • Friends Partners With James Graham Brown Cancer Center for Community Town Hall
      • Friends, Howard University and Avon Foundation Co-Host Town Hall
    • Disparities Symposium at GWU
    • Kansas Town Hall
    • Friends & Lombardi Hold Cancer Health Disparities Forum
    • Brookings, Friends, AACR and ASCO Host Conference on Clinical Cancer Research
    • Friends Partners With James Graham Brown Cancer Center for Community Town Hall
  • Upcoming Events
    • CQ - While Disparities Persist, Cancer Screening Rates Equalize for African Americans
    • Inside Health Policy - FDA 2013 Approps Clouded By Unclear Impact of User Fees, Sequestration
    • Washington Post - PCORI: Funny acronym, serious work
    • Bloomberg - Drug Approvals Hit a Seven-Year High in 2011 on Improved Data
    • Reuters - Cancer rates in U.S. keep falling: report
    • Reuters - Targeted drug side effects add to cancer costs
    • WSJ - ‘War on Cancer’ Celebrates 40th Anniversary; What’s Next?.
    • FierceBiotech - Spike in approvals can't quell industry complaints about FDA
    • NYT - Scientific Panel Finds Few Clear Environmental Links to Breast Cancer
    • NYT - F.D.A. Revokes Approval of Avastin as Breast Cancer Drug
    • CER Priorities in Oncology Released
    • Reuters - FDA says drugs approved in U.S. before Europe
    • NYT - Obama Tries to Speed Response to Shortages in Vital Medicines
    • The Hill - The Prescription Drug and User Fee Act: An opportunity for progress in science and innovation
    • Reuters - Senators propose relaxing FDA conflict rules
    • NYT - U.S. Panel Advises Against Routine Prostate Test
    • Reuters - Cancer cost "becoming unsustainable" in rich nations
    • AACR CANCER PROGRESS REPORT
    • WSJ - Drug Shortages Threaten Cancer Research
    • CQ - Senate Appropriations Panel Trims NIH but Administers Half-Billion-Dollar Jolt to Drug Development
    • Bloomberg - NIH Budget Cuts May Slow Personalized Cancer Drugs, Group Says
    • CQ - Obama plan would make $320 billion in health cuts, including Medicare, Medicaid
    • CQ - FDA Reorganizes Approval of Cancer Therapies
    • Reuters - FDA may get two more months to review new drugs
    • WSJ - FDA, Brand Drug Firms Agree on Increased Fees
    • WSJ - When a Doctor Isn't Enough
    • Reuters - Gene therapy shown to destroy leukemia tumors
    • The Scientist - Debt Ceiling Bill May Hurt Science
    • Wall Street Journal - America's Innovation Agency: The FDA
    • WSJ - Drug Makers Refill Parched Pipelines
    • Roll Call - Sigal: FDA Requires Support, Funds to Continue Research
    • Reuters - Study: Cancer drugs approved in U.S. before Europe
    • The RPM Report - CATT in the Eye of the Beholder: Top Government Officials React to Comparative Study
    • WSJ - Major Shift in War on Cancer
    • Washington Post - NIH human clinical trials look for causes and cures for disease
    • The Economist - The costly war on cancer
    • CNBC - The Arrival of Personalized Medicine
    • WSJ - Sanofi’s Zerhouni On Translational Research: No Simple Solution.
    • The New York Times - The Voices of Childhood Cancer
    • National Journal - The Late Sen. Stevens' Spouse Fights a New Battle
    • SF Gate - Scientific progress starts with us
    • The Washington Examiner - To cut costs, health care needs much more info
    • CQ - Report: More Research Needed on Causes of Cancer Among Minorities
    • The Atlantic - People, or Rules?
    • GenomeWeb - Comparative Effectiveness Research to Advance Personalized Rx in FDA's Five-Year Plan
    • The Wall Street Journal - Making Clinical Trials Less of a Tribulation
    • The Pink Sheet - PDUFA V: FDA Relaxes Pre-Submission Meeting Requirement
    • Nature - Transparency initiative moves ahead despite official’s departure
    • NEJM - Development of Novel Combination Therapies
    • Inside Health Policy - Bennet To Expand Drug Safety Bill, Expected To Gain GOP Support
    • Inside Health Policy - FDA's Initial CER Studies To Develop Trial Designs, Analytic Software
    • GW Today - Eliminating Breast Cancer Disparities
    • Voices of Survivors - 'My Voice' by Pamela Grossman
    • The Pink Sheet - PCORI Board Lays CER Groundwork With Environmental Scans, “Tier 1” Grants
    • FDA and Its Regulated Industries Are a Cornerstone of U.S. Economic Growth
    • CQ - First Steps on Comparative Effectiveness Grants Expected Next Week
    • Politics Daily - The GOP Budget and Cancer -- Why New Research Is at Risk
    • Press Release - FDA and Georgetown University Medical Center announce partnership
    • Nature - It takes two to tango: FDA ponders a new regulatory dance
    • RPM Report - How To Strengthen a Chronically Underfunded FDA: Cut Funding
    • WSJ - Health-Care Investment—The Hidden Crisis
    • Washington Post Letter to the Editor - Drug approval isn't a race between the U.S. and the E.U.
    • The New York Times - Awaiting Health Law's Prognosis
    • CQ - Comparative Effectiveness Institute Ramps Up Work
    • Health Affairs - HHS Secretary Kathleen Sebelius: Building a Stronger Foundation for a New Century of Treatments and Cures
    • HHS - New report: 129 million Americans with a pre-existing condition could be denied coverage without new health reform law
    • WSJ - Cancer-Care Costs Could Hit $207 Billion in 2020: NCI Study
    • U.S. News and World Report - Quality of Life Key Measure in Breast Cancer Clinical Trials
    • The Wall Street Journal - Regulator Defends Avastin Decision
    • The Pink Sheet - FDA Draft Co-Development Guidance Emphasizes Phase II Studies
    • Reuters - U.S. and Europe to limit use of Roche's Avastin
    • WSJ - FDA: Here’s How to Develop Drug Combinations
    • Reuters - Elizabeth Edwards dies
    • The Pink Sheet - Observational Study Guidance Needed for CER
    • Fuel Lines of Tumors Are New Target
    • The Wall Street Journal - Medicare to Review Cancer Treatment
    • Reuters - FDA chief urges caution on budget cut
    • The Wall Street Journal - 'Too Young for Cancer' and Demanding Action
    • Science Based Medicine - Integrating patient experience into research and clinical medicine: Towards true “personalized medicine”
    • The New York Times - CT Scans Can Reduce Lung Cancer Deaths, Study Finds
    • The Pink Sheet - CER Could Be A Barrier To Innovation, Venture Capitalist Says
    • The New York Times - New DNA Tests Aimed at Reducing Colon Cancer
    • The Health Care Blog - How Come Comparative Effectiveness Research is All the Rage?
    • WSJ Health Blog - Prevention Task Force Cancels Nov. Meeting; Would Have Included Prostate Screening Vote
    • Kaiser Health News- Daschle On Health Law: Defunding Is 'A Very Serious Threat'
    • Reuters- UnitedHealth seeks change to reimbursing for cancer drugs
    • San Francisco Business Times- Cancer network favors Avastin — mostly
    • Wash Post: New government panel's mission is to empower public with health-care knowledge
    • Regulatory Science: A Biodefense Backlash?
    • AP- FDA plans to collaborate with outside researchers to improve food, drug science
    • NPR- Court: Stem Cell Funds Can Continue For Now
    • Wall Street Journal - Health Insurers Finally Get Some Oversight
    • The Hill- GAO announces appointments to comparative-effectiveness board
    • NY Times- Mammograms’ Value in Cancer Fight at Issue
    • New York Times- New Drugs Stir Debate on Basic Rules of Clinical Trials
    • NY Times- Is Newer Better? Not Always
    • AP- Appeals court allows stem cell funding for now
    • Reuters- Obama administration appeals stem cell injunction
    • Washington Post- NIH cuts off stem cell funding after court order
    • Reuters- U.S. court rules against Obama's stem cell policy
    • LA Times- Avastin shouldn't make the FDA give up on 'accelerated approval' of drugs
    • Washington Post-FDA considers revoking approval of Avastin for advanced breast cancer
    • FORTUNE- The preventative medicine problem: nobody wants it
    • DNA Test May Speed Colon Cancer Diagnosis
    • AP- Health Care Reform Provisions To Go Into Effect Next Month
    • Reuters- U.S. panel rejects Roche's Avastin for breast cancer
    • Reuters- U.S. Advisers Say Keep Glaxo's Avandia on the Market
    • Science Mag- Varmus Targets 'Dysfunction,' Scientific Barriers in Cancer Research
    • The Kansas City Star- Turning science into drugs a trial
    • Lawrence Journal World- Sebelius calls for expedited drug process
    • HHS Secretary Sebelius Joins Leaders from the National Institutes of Health, Food & Drug Administration and Academia to Discuss New Roles in Drug Discovery and Development
    • Boston Globe- Rethinking cancer treatment
    • Health Affairs- Rapid Learning And Cancer Care: Time To Move Forward
    • Reuters- Pfizer pulls leukemia drug from U.S. market
    • Economist- A decade after the human-genome project, writes Geoffrey Carr, biological science is poised on the edge of something wonderful
    • Inside Health Policy- FDA Struggles With How To Regulate Co-Development Of Drugs, Seeks Input
    • CNN- Three questions with Dr. Francis Collins
    • WSJ- A New Way to Treat Brain Cancer?
    • Science Magazine- Francis Collins: On Recruiting Varmus, Discovering Drugs, the Funding Cliff
    • Washington Post- Ex-NIH chief and Nobel winner returns to lead National Cancer Institute
    • New York Times- Nobelist Is Chosen to Fill Cancer Post
    • The Scientist- Fate of science "hero" uncertain
    • WHYY- Biomedical community watching primary closely
    • Business Week- Prostate Cancer Vaccine May Get FDA Approval
    • NY Times- Faltering Cancer Trials
    • New York Times- Cancer Fight: Unclear Tests for New Drug
    • Washington Times- WEINER & BERG: 'Failure' is the wrong diagnosis
    • Bloomberg- Cancer Research by U.S. Disorganized, Underfunded, Study Says
    • WSJ- Another Cancer Battle: Costs
    • Francis Collins on CER and Personalized Medicine
    • Washington Post- John Dingell's health-care moment
    • Washington Post- Conversations: NIH Director Francis S. Collins
    • JAMA- Charting a Path From Comparative Effectiveness Funding to Improved Patient-Centered Health Care
    • The President's Remarks on Health Care
    • The Center for Health Transformation- Research is the Foundation of All New Advances in Medicine
    • Boston Globe - To trim medical costs, apply ‘best practices’
    • Chronicle of Higher Education- On Climate Controversies and AIDS Research, Scientists Reach Out to the Public
    • Annals of Internal Medicine- When Evidence Collides With Anecdote, Politics, and Emotion: Breast Cancer Screening
    • WSJ- A Simple Health-Care Fix Fizzles Out
    • WSJ- Public Health Tab to Hit Milestone
    • Freeze? What freeze? FDA in line for another budget boost
    • AP- Rangel: Lawmakers writing compromise health bill
    • Philadelphia Inquirer- FDA has more work, less money
    • Text: President Obama’s State of the Union Address
    • New York Times- As Technology Surges, Radiation Safeguards Lag
    • Politico- Five key health reform questions
    • Reuters- SCENARIOS-U.S. healthcare bill faces uncertain fate
    • ABC NEWS- Obama: Seat Scott Brown and Health Care Next Steps
    • New York Times- Democrats May Seek to Push Health Bill Through House
    • Washington Post- Meet the conference committee
    • HOUSE-SENATE COMPARISON OF KEY PROVISIONS
    • Washington Post- During health-care vote, Ted Kennedy is gone -- but not forgotten
    • New York Times- Old Ideas Spur New Approaches in Cancer Fight
    • Politico- Group mobilizes against new recs
    • New York Times- When Lowering the Odds of Cancer Isn’t Enough
    • New York Times- Cancer Society Protests Senate’s Proposed Cap on Benefits
    • WSJ- The Imprecision Behind Mammogram Guidance
    • WSJ- Cancer Rates Continue to Fall in the U.S.
    • The Associated Press- Senate casts 1st votes to overhaul health care
    • Washington Post- Fighting a smarter war on cancer
    • Washington Post- Behind Cancer Guidelines, Quest for Data
    • Washington Post- Let's stick with mammograms
    • SEBELIUS STATEMENT ON NEW BREAST CANCER RECOMMENDATIONS
    • Washington Post- Breast exam guidelines now call for less testing
    • Indy Star- Vera Bradley Foundation to give another $10M to IU cancer center
    • Health Bill Garners Endorsements
    • Washington Post- FDA initiative targets drug prescription, dosing errors
    • Pink Sheet- CER And Personalized Medicine Are "Synergistic" - FDA's Woodcock
    • New York Times- A Place Where Cancer Is the Norm
    • The Hill- How the two Senate bills measure up
    • New York Times- Merging the Senate Bills
    • Philadelphia Inquirer- A few seconds for science
    • Reuters- Rep. DeLauro, Administration Urge Congress to Improve the Safety of Imported Food
    • Fortune-FDA chief: Regaining your trust
    • AP- Another GOP senator open to health overhaul
    • RPM Report Interview with Ellen Sigal
    • New York Times- Health Care Bill Gets Green Light in Cost Analysis
    • Wall Street Journal- Hospitals Find Way to Make Care Cheaper -- Make It Better
    • New York Times- For N.I.H. Chief, Issues of Identity and Culture
    • Associated Press -Obama Announces $5 Billion in Health-Research Grants
    • Wall Street Journal- Making Sense of the Debate on Health Care
    • USA TODAY-Health care comparisons help show best practices, prices
    • Pink Sheet- FDA Will Revisit Appropriate Use Of PFS Endpoints At Advisory Committee
    • New York Times- Where Cancer Progress Is Rare, One Man Says No
    • Wall Street Journal- Baucus Crafts Health Care Plan, But Senate Democrats Have Concerns
    • Washington Post- Dodd Decides Against Taking Over Senate Health Committee
    • New York Times- Health Compromise Floated Before Obama Speech
    • Wall Street Journal- Bleak Cancer Reports Mask Major Advances
    • Huffington Post- The Future We Make: Ted Kennedy's Legacy in Fighting Cancer
    • New York Times- The Selling of the Policy
    • LA Times- Amid the acrimony, Congress has consensus on some healthcare issues
    • Washington Post- Massachusetts Sen. Ted Kennedy Dies at 77 After Cancer Battle
    • Newsweek- Five Important Health Care Reforms We Aren't Talking About
    • New York Times- Disparities: Study Finds Risk in Off-Label Prescribing
    • New York Times- Daschle Has Ear of White House and Industry
    • Huffington Post- Solving the Healthcare Reform Puzzle
    • Boston Globe- Dispute widens on merits of health tests
    • Reuters- Drug compound kills breast cancer stem cells
    • New York Times-10 Steps to Better Health Care
    • The New York Times-Why Patients Turn Down Clinical Trials
    • The New York Times- A Primer on the Details of Health Care Reform
    • New York Times- To Fight Cancer, Know the Enemy
    • New York Times- Lack of Study Volunteers Hobbles Cancer Fight
    • AP- Dodd has prostate cancer
    • Washington Post- Baucus Touts Lower Cost of Compromise Health-Care Bill
    • Washington Post- Key Lawmakers Restart Health-Care Talks
    • NPR- Health Effects Of Comparing Care: No Easy Answers
    • Newsweek- ‘The Cause of My Life’... Inside the fight for universal health care.
    • DOW JONES NEWSWIRES - US Senate Panel Approves 12-Year Biologic Drug Exclusivity
    • NY Times- Health Reform, a Cancer Offers an Acid Test
    • AP-Which treatment works best?
    • Time- How to Cut Health-Care Costs: Less Care, More Data
    • USA TODAY- FDA has a lot on its plate' as new chief takes over
    • New York Times- Senate Moves Forward on Health Care
    • MSNBC- How numbers crunchers shape health reform
    • Nextgov- Health professionals call for network to uncover best medical treatments
    • LA Times-Healthcare overhaul effort moves forward without Kennedy
    • Boston Globe- Health bill would fix what's broken
    • The FDA as a Public Health Agency
    • Pink Sheet- House Comparativeness Effectiveness Bill includes “Physician Out” Clause
    • NCI- Comparative Effectiveness Research Stirs Excitement as Well as Debate
    • Associated Press- Nominee to Lead FDA Confirmed By Senate
    • Wall Street Journal- Health Costs Are the Real Deficit Threat
    • The Pink Sheet- Senate Adding Safeguards Against Direct Link Between Comparative Effectiveness Research, Coverage Decisions
    • NPR: Orszag: Health Coalition's Plan A 'Significant' Step
    • Washington Post- Senators Offer Their Support to F.D.A. Nominee
    • Wall Street Journal- Obama Wants Additional $300 Million for FDA
    • AACI, AACR, ASCO, and Friends host Hill Day 2009, and Honor Senator Arlen Specter
    • Power for patients: Comparative effectiveness research will help people make better health choices
    • Sebelius Confirmation Expected Today
    • New York Times- Health Care Reform, Step One
    • New York Times- Advances Elusive in the Long Drive to Cure Cancer
    • CQ- ‘White Paper’ Aims to Shape Treatment Comparison Agenda
    • Washington Post- Local, State Agencies Lack Resources to Ensure Food Safety
    • Comparative effectiveness research panel holds first session
    • Wall Street Jounral- Push to Compare Treatments Worries Drug, Device Makers Article
    • Washington Post- Obama Makes Health Reform Office Official
    • Wall Street Journal- Torti’s Farewell Memo to FDA Staff: ‘Take the FDA Back’
    • FDA Week- Sentinel Could Help Choose Comparative Effectiveness Projects
    • Houston Chronicle- Now’s time to reinvigorate country’s War on Cancer
    • Washington Post- After Cancer, Lawmaker Urges Tests
    • Dow Jones- Roche's Herceptin Extends Life In Aggressive Stomach Cancer
    • Comparison Shopping for Medicine
    • Obama to tap Hamburg to run FDA
    • FDA Pick Was NYC Health Chief
    • RPM Report - FDA Commissioner Hamburg: Administration Closing In On Official Announcement
    • Wall Street Journal - Obama, Health-Care Players Agree to Seek Overhaul
    • Washington Post - White House forum to diagnose health care ills
    • WSJ - Obama Taps Sebelius for Health and Human Services Secretary
    • New York Times - On Health, President Takes Team Approach
    • WSJ - The Next Front in the War on Cancer
    • Reuters - Obama Cancer Cure Vow Requires More Funds: Experts
    • The Scientist - Flat funding for NIH in 2009
    • Reuters-Sebelius says has not discussed health post with Obama
    • The Huffington Post- Why Healthcare Can’t Wait
    • New York Times - Specter, a Fulcrum of the Stimulus Bill, Pulls Off a Coup for Health Money
    • The Hill - Dem ‘family politics’ blocks Dean at HHS
    • The Scientist - Biomedical research is ripe for a stimulus
    • Washington Post- I'm Battling Cancer. How About Some Help, Congress?
    • Wall Street Journal - Understanding Justice Ginsburg’s Pancreatic Cancer
    • RPM Report-FDA Commissioner Update: Announcement Timing Provides Clues
    • SystemsTox
    • Reuters: Obama's FDA pick to come within days-spokesman
    • New York Times - Medicare Widens Drugs It Accepts for Cancer
    • Wall Street Journal - CDC Insider Named Acting Director
    • Wall Street Journal - CDC, FDA Set to Get New Leaders
    • New York Times - Daschle Pledges a Bipartisan Reform of Health Care System
    • Boston Globe - The Great Promise of Personalized Medicine
    • Washington Post- Next NIH Director Faces Budget Issues
    • Boston Globe - America Needs a Strong FDA
    • Washington Post - Ailing FDA May Need Major Reconstructing
    • Capitol File- Two Views One Goal
• Resources
  • FDA Advocacy
    • BNA- Speakers Say FDA Cannot Fulfill Mission Without Additional Resources, Collaboration
    • Inside Health Policy- FDA Eyes Setting Up Two CER Centers To Leverage Agency Data
  • Appropriations
  • Jobs & Internships
    • Science Policy Analyst 2
    • 2011 Summer Internships
    • download documents
  • Links
• Comparative Effectiveness Research
  • CER Documents
  • CER Legislation
  • PCORI
• FDA Advocacy
  • FDA and Cancer
  • FDA News and Legislation
• Donate
  • Policy on Corporate Relationships

Header Menu

• Site Map
• Terms & Conditions
• Privacy Policy
• Contact

• Annual Report
• Search
• Custom Properties